TScan Therapeutics (TCRX)
(Delayed Data from NSDQ)
$5.63 USD
-0.01 (-0.18%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $5.66 +0.03 (0.53%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For TCRX
-
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Lags Revenue Estimates
-
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
-
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates
-
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Misses Revenue Estimates
-
TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Tops Revenue Estimates
-
TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
-
TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update